Replies to post #6495 on Intellect Neurosciences Inc. (fka ILNS)

[streetsmartstocks]

Let the money train begin...

CONJUMAB-A is a first-in-class drug compound intended to address an important unmet need in AMD, which is the leading cause of blindness in people over the age of 55.

This is HUGE!

IF/When this hits the news wire the stock must react to higher.

Peace.